Abivax SA American Depositary Shares (ABVX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.67B
Last updated: Nov 17, 2026 at 11:04 AM ET
Abivax SA American Depositary Shares (ABVX) Competitors
The companies most similar to Abivax SA American Depositary Shares are Immunovant (IMVT), Vaxcyte (PCVX) and Axsome Therapeutics (AXSM). By market cap, Abivax SA American Depositary Shares ranks 6th of the 13 companies on this page; Summit Therapeutics (SMMT) is the largest at $11.32B.
Peer Comparison
ABVX's ROIC of -159.6% is below the peer median of -35.6%, and its revenue growth of -6.8% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Abivax SA American Depositary Shares (ABVX) | $7.67B | N/A | N/A | 0.0% | -159.6% | -6.8% | 0.00% |
| Immunovant Inc (IMVT) | $7.07B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vaxcyte Inc (PCVX) | $10.03B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Axsome Therapeutics Inc (AXSM) | $7.45B | N/A | 8.6x | -18.2% | -48.1% | 51.9% | 0.00% |
| Immunitybio Inc (IBRX) | $6.40B | N/A | 30.3x | 0.0% | -780.5% | 52.3% | 0.00% |
| Apogee Therapeutics, Inc. Common Stock (APGE) | $10.22B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CG Oncology, Inc. Common stock (CGON) | $6.65B | N/A | N/A | 0.0% | -21.1% | -3.7% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Kodiak Sciences Inc (KOD) | $7.27B | N/A | N/A | 0.0% | -1481.8% | 0.0% | 0.00% |
| Erasca Inc (ERAS) | $5.50B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| Peer median | $7.36B | 87.2x | 9.9x | 0.0% | -35.6% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Abivax SA American Depositary Shares, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Immunovant Inc (IMVT) | Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. | IMVT competitors |
| Vaxcyte Inc (PCVX) | Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally. | PCVX competitors |
| Axsome Therapeutics Inc (AXSM) | Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United... | AXSM competitors |
| Immunitybio Inc (IBRX) | ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose... | IBRX competitors |
| Apogee Therapeutics, Inc. Common Stock (APGE) | Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)... | |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| CG Oncology, Inc. Common stock (CGON) | CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing groundbreaking cancer therapies, particularly through its lead product, CG0070... | CGON competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Kodiak Sciences Inc (KOD) | Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing... | KOD competitors |
| Erasca Inc (ERAS) | Erasca Inc. is a pioneering biopharmaceutical firm specializing in the development of targeted therapies for genetically defined cancers... | ERAS competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
Frequently Asked Questions About ABVX
Who are Abivax SA American Depositary Shares' main competitors?
The companies most similar to Abivax SA American Depositary Shares include Immunovant (IMVT), Vaxcyte (PCVX), Axsome Therapeutics (AXSM), Immunitybio (IBRX) and Apogee Therapeutics, Inc. Common Stock (APGE), listed from the closest match.
Who is Abivax SA American Depositary Shares' biggest competitor?
Summit Therapeutics (SMMT) is the largest of the similar companies at $11.32B; Immunovant (IMVT) is the closest match by business profile, size, sector and industry.
How does ABVX stock compare with its competitors?
ABVX's net margin is 0.0% against a peer median of 0.0%.
Which of Abivax SA American Depositary Shares' competitors pays a higher dividend?
Abivax SA American Depositary Shares pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Abivax SA American Depositary Shares bigger than its competitors?
No. Abivax SA American Depositary Shares is 6th by market cap among the 13 companies on this page; the largest is Summit Therapeutics (SMMT) at $11.32B.
ABVX pages: Overview, Financials, Competitors